US 6800626
Inhibitors of p38
expired A61PA61P1/04A61P1/18
Quick answer
US patent 6800626 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 05 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P1/04, A61P1/18, A61P11/00, A61P11/06